Bipolar Disorder Trial, Recruiting NCT07534475 Sponsor: Medipol University Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT07534475
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already scheduled to receive Electroconvulsive Therapy (ECT) as a planned, non-emergency procedure.
  • People whose overall physical health falls within a low-to-moderate risk range as assessed by their anaesthetist (confirm with trial site).

Who may not be able to join:

  • People with a known condition affecting the muscles or the nerves that control them (for example, Myasthenia Gravis).
  • People with a known allergy or sensitivity to any of the following medications: sugammadex, rocuronium, ketamine, dexmedetomidine, or propofol.
  • People who have poor vein function, swelling caused by fluid build-up in the arms, or an active infection in either arm or hand.
  • People with serious instability in their heart or blood circulation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medipol University
Registry
ClinicalTrials.gov
Start date
20 April 2026
Est. completion
30 November 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Motor Seizure Duration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov